• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Clinical Chemistry Creatine Kinase

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Clinical Chemistry Creatine Kinasesee related information
Date Initiated by FirmOctober 12, 2007
Date PostedMarch 19, 2008
Recall Status1 Terminated 3 on March 28, 2012
Recall NumberZ-1109-2008
Recall Event ID 46387
510(K)NumberK983070 
Product Classification cpk or isoenzymes nad reduction - Product Code CGS
ProductAbbott Clinical Chemistry Creatine Kinase, Model LN 7D63-30, Lot Number: 52044HW00; Expires October 19, 2007, RCR#2018433-10/25/07-006R Abbott Laboratories, Inc., South Pasadena CA 91030
Code Information Lot Number: 52044HW00
Recalling Firm/
Manufacturer
Abbott Laboratories Inc.
820 Mission St
South Pasadena CA 91030-3142
For Additional Information ContactMark Littlefield
972-518-6062
Manufacturer Reason
for Recall
Three potential issues with Creatine Kinase Lot Number: 52044HW00: (1) Decrease in quality control and/or patient results (2) An iIncreased imprecision, or (3) Error Code 1054 (Unable to calculate results, Reaction Failure) on Architect cSystems.
FDA Determined
Cause 2
Nonconforming Material/Component
ActionOn October 12, 2007, A Product Recall letter was provided to all Clinical Chemistry Creatine Kinase Reagent customers that have received lot number 52044HW00 . Customer reply form were included in all US customers letter. The letter instructed customers to discontinue use of the kits and destroy them following their laboratory procedure, and document the number of kits discarded. Abbott will provide reimbursement for destroyed kits.
Quantity in Commerce334 Distributed Worldwide; 164 Domestically
DistributionWorldwide Distribution --- including USA and countries of Canada, Chili, Uruguay, Germany, Hong Kong, and New Zealand.
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
510(K) Database510(K)s with Product Code = CGS
-
-